Background: Literature often focuses on loneliness as a risk factor for dementia. However, loneliness among those living with dementia (PLWD) is yet to be further explored.

Method: Secondary analysis of the English Longitudinal Study of Ageing. Across ELSA waves 1 to 9, we identified 181 participants who reported being diagnosed with dementia and randomly selected 775 (10%) non-dementia participants (NDP) from wave 2 (2004-2005). For PLWD, the baseline was the year they reported the diagnosis. For NDP, the baseline was information from waves 1 and 2. We obtained a two-year lagged loneliness for a subsample (n = 70 PLWD and n = 569 NDP). We computed multiple linear regression models using bootstrap errors with 1000 iterations to describe the average levels of loneliness among people living with dementia in England.

Result: Both groups did not differ in their socioeconomic characteristics except for age. PLWD were, on average, 76 years old (Sd = 9.74), and NDP was 66 years old (sd = 9.53). The average level of loneliness was 4.71 (sd = 1.74) for PLWD and 4.07 (sd = 1.47) for NDP. At baseline, the loneliness prevalence was 15.76% among PLWD and 7.55% for NDP. Among PLWD, the average 2-year lagged loneliness was 4.72 (sd = 1.79), and 21% reported problematic loneliness, and among NDP, it was 4.18 (sd = 1.52) and 10%, respectively. Adjusted baseline levels of loneliness were statistically significantly higher among PLWD (Coef. = 0.694; 95% CI: 0.393-0.994). For the 2-year lagged loneliness, dementia and non-dementia participants did not significantly differ in their levels of loneliness.

Conclusion: Public policies should consider tackling loneliness among people living with dementia.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.088901DOI Listing

Publication Analysis

Top Keywords

living dementia
12
lagged loneliness
12
loneliness
11
plwd
8
non-dementia participants
8
ndp baseline
8
levels loneliness
8
loneliness people
8
people living
8
plwd average
8

Similar Publications

Background And Objectives: Cerebrovascular reactivity (CVR) represents the ability of cerebral blood vessels to regulate blood flow in response to vasoactive stimuli and is related to cognition in cerebrovascular and neurodegenerative conditions. However, few studies have examined CVR in the medial temporal lobe, known to be affected early in Alzheimer disease and to influence memory function. We aimed to examine whether medial temporal CVR is associated with memory function in older adults with and without mild cognitive impairment (MCI).

View Article and Find Full Text PDF

Background: Reactive astrogliosis refers to functional and morphological changes in astrocytes that occur with neuronal damage in numerous neurological conditions. PET tracers targeting monoamine oxidase B (MAO-B) are used to visualize reactive astrogliosis in the living brain. [F]SMBT-1, a MAO-B selective PET tracer, was developed by modifying the chemical structure of [F]THK5351.

View Article and Find Full Text PDF

Background: The nuclear clearance and cytoplasmic aggregation of splicing repressor TAR DNA/RNA-binding protein-43 (TDP-43) occur in approximately 50% of Alzheimer's disease (AD) cases and about 45% of frontotemporal dementia (FTD). However, it is not clear how early such mechanism occurs in AD and FTD as there is no method of detecting TDP-43 dysregulation in living individuals. Since the loss of nuclear TDP-43 leads to cryptic exon inclusion, we propose that cryptic exon-encoded peptides may be detected in patient biofluids as biomarkers of TDP-43 loss of function.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Biogen, Cambridge, MA, USA.

Background: Intrathecally (IT) delivered antisense oligonucleotides (ASOs) are promising therapies that can reduce tau pathology in Alzheimer's Disease (AD). However, current plasma and CSF sampling methods to estimate brain tissue exposure of ASOs are inherently limited, hampering ASO clinical developmental plans. We developed the PET tracer [F]BIO-687, which binds ASO conjugates (ASO-Tz) in vivo, allowing us to image ASO distribution in a living brain using "pretargeted" imaging.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Cognitive Neuroscience Centre, University of San Andres, Victoria, Buenos Aires, Argentina.

Background: Dementia impacts the way individuals perceive and describe everyday events. Alzheimer's disease (AD) notably affects processing of entities manifested by nouns, while behavioral variant frontotemporal dementia (bvFTD) often presents a detached, third-person perspective. Yet, the potential of natural language processing tools (NLP) to detect these variations in spontaneous speech remains explored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!